The effect of percutaneous renal denervation on muscle sympathetic nerve activity in hypertensive patients

International Journal of Cardiology

Volumn 176, Issue 1, 2014, Pages 8-12

  Vink, E E ^a   Verloop, W L ^a   Siddiqi, L ^a   Van Schelven, L J ^a   Liam Oey, P ^a   Blankestijn, P J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Blood pressure; Muscle sympathetic nerve activity; Renal denervation; Resistant hypertension; Sympathetic activity

Indexed keywords

ACETYLSALICYLIC ACID; ALISKIREN; AMLODIPINE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM ANTAGONIST; CAPTOPRIL; CLONIDINE; DOXAZOSIN; HYDROCHLOROTHIAZIDE; LABETALOL; LOSARTAN; METOPROLOL; SPIRONOLACTONE; VERAPAMIL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; DRUG WITHDRAWAL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN CELL; KIDNEY DENERVATION; MALE; MUSCLE SYMPATHETIC NERVE ACTIVITY; PERCUTANEOUS RENAL DENERVATION; PRIORITY JOURNAL; RESISTANT HYPERTENSION; RESTING HEART RATE; SYSTOLIC BLOOD PRESSURE; CATHETER ABLATION; FOLLOW UP; HYPERTENSION; INNERVATION; KIDNEY; KIDNEY ARTERY; MIDDLE AGED; PROCEDURES; SYMPATHECTOMY; SYMPATHETIC NERVE CELL; TREATMENT OUTCOME; VASCULARIZATION;

ADULT; AGED; CATHETER ABLATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; KIDNEY; MALE; MIDDLE AGED; RENAL ARTERY; SYMPATHECTOMY; SYMPATHETIC FIBERS, POSTGANGLIONIC; TREATMENT OUTCOME;

EID: 84906320947     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.06.021     Document Type: Article

References (35)

1. P.M. Kearney, M. Whelton, K. Reynolds, P. Muntner, P.K. Whelton, and J. He Global burden of hypertension: analysis of worldwide data Lancet 365 2005 217 223 (Pubitemid 40138015)
2. M. Pereira, N. Lunet, A. Azevedo, and H. Barros Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries J. Hypertens. 27 2009 963 975
3. M.P. Schlaich, P.A. Sobotka, H. Krum, R. Whitbourn, A. Walton, and M.D. Esler Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept Hypertension 54 2009 1195 1201
4. H. Krum, M. Schlaich, R. Whitbourn, P.A. Sobotka, J. Sadowski, and K. Bartus et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study Lancet 373 2009 1275 1281
5. M.D. Esler, H. Krum, P.A. Sobotka, M.P. Schlaich, R.E. Schmieder, and M. Bohm Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial Lancet 376 2010 1903 1909
6. symplicity HTN-1 Investigators Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months Hypertension 57 2011 911 917
7. P.J. Blankestijn, and E. Ritz Renal denervation: potential impact on hypertension in kidney disease? Nephrol. Dial. Transplant. 26 2011 2732 2734
8. G. Ligtenberg, P.J. Blankestijn, P.L. Oey, I.H. Klein, L.T. Dijkhorst-Oei, and F. Boomsma et al. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure N. Engl. J. Med. 340 1999 1321 1328 (Pubitemid 29196594)
9. I.H.H.T. Klein, G. Ligtenberg, P.L. Oey, H.A. Koomans, and P.J. Blankestijn Sympathetic activity is increased in polycystic kidney disaese and is associated with hypertension Journal of the American Society of Nephrology 12 2001 2427 2433 (Pubitemid 33021120)
10. I.H. Klein, G. Ligtenberg, P.L. Oey, H.A. Koomans, and P.J. Blankestijn Enalapril and losartan reduce sympathetic hyperactivity in patients with chronic renal failure J. Am. Soc. Nephrol. 14 2003 425 430 (Pubitemid 36150866)
11. I.H. Klein, G. Ligtenberg, J. Neumann, P.L. Oey, H.A. Koomans, and P.J. Blankestijn Sympathetic nerve activity is inappropriately increased in chronic renal disease J. Am. Soc. Nephrol. 14 2003 3239 3244 (Pubitemid 37509299)
12. J. Neumann, G. Ligtenberg, L. Oey, H.A. Koomans, and P.J. Blankestijn Moxonidine normalizes sympathetic hyperactivity in patients with eprosartan-treated chronic renal failure J. Am. Soc. Nephrol. 15 2004 2902 2907 (Pubitemid 41103399)
13. J. Neumann, G. Ligtenberg, I.H. Klein, P. Boer, P.L. Oey, and H.A. Koomans et al. Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment Hypertension 49 2007 506 510
14. O. Zilch, P.F. Vos, P.L. Oey, M.J. Cramer, G. Ligtenberg, and H.A. Koomans et al. Sympathetic hyperactivity in haemodialysis patients is reduced by short daily haemodialysis J. Hypertens. 25 2007 1285 1289 (Pubitemid 46918809)
15. L. Siddiqi, N.H. Prakken, B.K. Velthuis, M.J. Cramer, P.L. Oey, P. Boer, and M.L. Bots et al. Sympathetic activity in chronic kidney disease patients is related to left ventricular mass despite antihypertensive treatment Nephrol. Dial. Transplant. 25 2010 3272 3277
16. L. Siddiqi, P.L. Oey, and P.J. Blankestijn Aliskiren reduces sympathetic nerve activity and blood pressure in chronic kidney disease patients Nephrol. Dial. Transplant. 26 2011 2930 2934
17. L. Siddiqi, J.A. Joles, P.L. Oey, and P.J. Blankestijn Atorvastatin reduces sympathetic activity in patients with chronic kidney disease J. Hypertens. 29 2011 2176 2180
18. M.P. Schlaich, P.A. Sobotka, H. Krum, E. Lambert, and M.D. Esler Renal sympathetic-nerve ablation for uncontrolled hypertension N. Engl. J. Med. 361 2009 932 934
19. D. Hering, E.A. Lambert, P. Marusic, A.S. Walton, H. Krum, and G.W. Lambert et al. Substantial Reduction in Single Sympathetic Nerve Firing After Renal Denervation in Patients With Resistant Hypertension Hypertension 61 2012 457 464
20. J. Brinkmann, K. Heusser, B.M. Schmidt, J. Menne, G. Klein, and J. Bauersachs et al. Catheter-Based Renal Nerve Ablation and Centrally Generated Sympathetic Activity in Difficult-to-Control Hypertensive Patients: Prospective Case Series Hypertension 60 2012 1485 1490
21. M.P. Schlaich, B. Bart, D. Hering, A. Walton, P. Marusic, and F. Mahfoud et al. Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease Int. J. Cardiol. 168 2013 2214 2220
22. W.L. Verloop, E.E. Vink, M. Voskuil, E.J. Vonken, M.B. Rookmaaker, and M.L. Bots et al. Eligibility for percutaneous renal denervation: the importance of a systematic screening J. Hypertens. 31 2013 1662 1668
23. A.B. Vallbo, K.E. Hagbarth, H.E. Torebjork, and B.G. Wallin Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves Physiol Rev. 59 1979 919 957 (Pubitemid 10191396)
24. P. Rossi, G.I. Andriesse, P.L. Oey, G.H. Wieneke, J.M. Roelofs, and L.M. Akkermans Stomach distension increases efferent muscle sympathetic nerve activity and blood pressure in healthy humans J. Neurol. Sci. 161 1998 148 155 (Pubitemid 28559168)
25. N.P. van Orshoven, P.L. Oey, L.J. van Schelven, J.M. Roelofs, P.A. Jansen, and L.M. Akkermans Effect of gastric distension on cardiovascular parameters: gastrovascular reflex is attenuated in the elderly J. Physiol 555 2004 573 583 (Pubitemid 38380012)
26. N.P. van Orshoven, G.I. Andriesse, L.J. van Schelven, A.J. Smout, L.M. Akkermans, and P.L. Oey Subtle involvement of the parasympathetic nervous system in patients with irritable bowel syndrome Clin. Auton. Res. 16 2006 33 39 (Pubitemid 43237900)
27. N.P. van Orshoven, L.J. van Schelven, L.M. Akkermans, P.A. Jansen, M. Horowitz, and C. Feinle-Bisset et al. The effect of intraduodenal glucose on muscle sympathetic nerve activity in healthy young and older subjects Clin. Auton. Res. 18 2008 28 35
28. A.S. Levey, L.A. Stevens, C.H. Schmid, Y.L. Zhang, A.F. Castro III, and H.I. Feldman et al. A new equation to estimate glomerular filtration rate Ann. Intern. Med. 150 2009 604 612
29. G. Grassi, F. Quarti-Trevano, G. Seravalle, F. Arenare, M. Volpe, and S. Furiani et al. Early sympathetic activation in the initial clinical stages of chronic renal failure Hypertension 57 2011 846 851
30. M.J. Joyner, N. Charkoudian, and B.G. Wallin A sympathetic view of the sympathetic nervous system and human blood pressure regulation Exp. Physiol 93 2008 715 724 (Pubitemid 351678599)
31. M.P. Schlaich, E. Lambert, D.M. Kaye, Z. Krozowski, D.J. Campbell, and G. Lambert et al. Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation Hypertension 43 2004 169 175 (Pubitemid 38174169)
32. E.E. Vink, R.L. de Jager, and P.J. Blankestijn Sympathetic hyperactivity in chronic kidney disease: pathophysiology and (new) treatment options Curr. Hypertens. Rep. 15 2013 95 101
33. D.L. Bhatt, D.E. Kandzari, W.W. O'Neill, R. D'Agostino, J.M. Flack, and B.T. Katzen et al. A controlled trial of renal denervation for resistant hypertension N. Engl. J. Med. 370 2014 1393 1401
34. Daniele N. Di, F.M. De, L. Violo, A. Spinelli, and G. Simonetti Renal sympathetic nerve ablation for the treatment of difficult-to-control or refractory hypertension in a haemodialysis patient Nephrol. Dial. Transplant. 27 2012 1689 1690
35. C. Ott, A. Schmid, T. Ditting, P.A. Sobotka, R. Veelken, and M. Uder et al. Renal denervation in a hypertensive patient with end-stage renal disease and small arteries: a direction for future research J. Clin. Hypertens. (Greenwich.) 14 2012 799 801